We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
351
Edwards Lifesciences
EW
$47.6B
$3.62M 0.06%
74,601
-33,711
-31% -$1.57M
GWPH
352
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.62M 0.06%
25,920
+2,500
+11% +$355K
DE icon
353
Deere & Co
DE
$170B
$3.58M 0.06%
25,638
+2,356
+10% +$347K
DOVA
354
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$3.57M 0.06%
119,200
+39,200
+49% +$1.07M
BSX icon
355
Boston Scientific
BSX
$65.8B
$3.56M 0.06%
108,985
+5,132
+5% +$155K
OPTU
356
Optimum Communications Inc
OPTU
$316M
$3.54M 0.06%
+207,635
New +$3.83M
ZGNX
357
DELISTED
Zogenix, Inc.
ZGNX
$3.54M 0.06%
80,000
-6,000
-7% -$247K
CTSH icon
358
Cognizant
CTSH
$21.5B
$3.52M 0.06%
44,562
-1,464
-3% -$115K
AES icon
359
AES
AES
$10.6B
$3.51M 0.06%
261,626
+224,034
+596% +$2.76M
CMS icon
360
CMS Energy
CMS
$23.1B
$3.46M 0.05%
73,237
+26,504
+57% +$1.2M
ALDR
361
DELISTED
Alder Biopharmaceuticals
ALDR
$3.44M 0.05%
217,500
+41,500
+24% +$631K
PFG icon
362
Principal Financial Group
PFG
$23.6B
$3.41M 0.05%
64,431
+13,723
+27% +$797K
OVV icon
363
Ovintiv
OVV
$17.5B
$3.38M 0.05%
51,849
-5,846
-10% -$367K
EQR icon
364
Equity Residential
EQR
$25.4B
$3.38M 0.05%
53,023
+22,004
+71% +$1.37M
TFC icon
365
Truist Financial
TFC
$63.2B
$3.37M 0.05%
66,898
-2,189
-3% -$116K
GM icon
366
General Motors
GM
$74.7B
$3.37M 0.05%
85,393
-25,158
-23% -$991K
AEP icon
367
American Electric Power
AEP
$73.7B
$3.35M 0.05%
48,378
-7,069
-13% -$476K
VFC icon
368
VF Corp
VFC
$6.68B
$3.35M 0.05%
43,591
+4,194
+11% +$316K
D icon
369
Dominion Energy
D
$62.5B
$3.32M 0.05%
48,722
-3,306
-6% -$215K
CMA
370
DELISTED
Comerica
CMA
$3.32M 0.05%
36,514
-91,606
-72% -$8.78M
ECL icon
371
Ecolab
ECL
$75.6B
$3.31M 0.05%
23,571
-21,103
-47% -$3.04M
TU icon
372
Telus
TU
$16B
$3.3M 0.05%
185,864
+25,290
+16% +$448K
NUE icon
373
Nucor
NUE
$56.4B
$3.3M 0.05%
52,767
+3,838
+8% +$245K
NTRS icon
374
Northern Trust
NTRS
$22.2B
$3.27M 0.05%
31,792
+10
+0% +$1.06K
GWW icon
375
W.W. Grainger
GWW
$65.3B
$3.22M 0.05%
10,455
-155
-1% -$46.3K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.